Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)

Triple-negative breast cancers (TNBC) are notoriously difficult to treat because they lack hormone receptors and have limited targeted therapies. Recently, we demonstrated that p90 ribosomal S6 kinase (RSK) is essential for TNBC growth and survival indicating it as a target for therapeutic developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Reipas, Kristen M., Law, Jennifer H., Couto, Nicole, Islam, Sumaiya, Li, Yvonne, Li, Huifang, Cherkasov, Artem, Jung, Karen, Cheema, Amarpal S., Jones, Steven J.M., Hassell, John A., Dunn, Sandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712578/
https://www.ncbi.nlm.nih.gov/pubmed/23593654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712578/
https://www.ncbi.nlm.nih.gov/pubmed/23593654

Ejemplares similares